GOMOTSISTEINGA BOG‘LIQ MIGREN RIVOJLANISHINING PATOGENETIK MEXANIZMLARI

Kambarova Dildora Noxidbekovna
Usmanova Durdona Djurabaevna
Nashr sanasi https://doi.org/10.56121/2181-3612-2023-3-26-27
TO'LIQ MATN:

Abstrakt

Maqolada migren rivojlanishida gomotsistein  ta’sirining turli mexanizmlari o‘rganiladi.   Gomotsistein, tarkibida oltingugurt bo‘lgan molekula, hozirgi vaqtda turli trombotik kasalliklar, asosan, yurak ishemik kasalligi va insultning mustaqil xavf omili sifatida  tan olingan.   Ushbu maqola  rivojlanishning turli mexanizmlari va gomotsistein bilan migrenning bog‘liqligini taqdim etishga qaratilgan bo‘lib,  bu davolashnin to‘g‘ri taktikasini tanlashga imkon beradi.

Nashr sanasi

Mualliflar haqida

Kambarova Dildora Noxidbekovna
Andijon davlat tibbiyot instituti
Usmanova Durdona Djurabaevna
Toshkent pediatriya tibbiyot instituti

Adabiyotlar ro'yxati

Cacciapuoti F. Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors. Blood Coag. Fibrinol. 2012; 23: 677– 9.

Tommaso MD, Losito L, Livrea P. The role of homocysteine in the pathogenesis and development of migraine. Cephalalgia 2005; 25: 823– 1020.

Lea A, Menon S, Colson NJ et al. Analysis of the MTHFR C677T variant with migraine phenotypes. BMC Res. Notes 2010; 3: 213.

Gavgani SC, Hoseinian MM. Comparative study on homocysteine levels in migraine patients and normal peoples. Ann. Biol. Res. 2012; 3(4): 1804– 7.

Hosseini M, Houshmad M, Ebraini A. MTHFR polymorphism and breast cancer risk. Arch. Med. Sci. 2011; 7: 134– 7.

Antoniades C, Shirodaria C, Leeson P et al. MTHFR 677 C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, no homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 2009; 119: 2507– 15.

Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetatrahydrofolate reductase gene is generic risk factor for migraine. Am. J. Med. Genet. 2000; 96: 762– 4.

Lorenz AL, Kahre T, Mihailov E et al. Are methylenetetrahydrofolate reductase (MTHFR) gene polymorphism C677T and A1298 C associated with higher risk of pediatric migraine in boys and girls? J. Biom. Sci. Eng. 2014; 7: 464– 72.

Liu R, Geng P, Ma M et al. MTHFR C677T ploymorfism and migraine risk: a meta-analysis. J. Neurol. Sci. 2014; 336: 68– 73.

Moskowitz MA. The neurobiology of vascular head pain. Ann. Neurol. 1984; 16: 157– 68.

Lea R, Colson N, Quinlan S, McMillan J, Griffiths L. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenet. Genomics 2009; 19: 422– 8.

Shaik MM, Gan SH. Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine. BioMed. Res. Intern. 2015. https://doi.org/10.1155/2015/469529

Tchantchou F, Graves M, Falcone D, Shea TB. S-adenosyl-methionine mediates glutathione efficacy by increasing glutathione-S-transferase activity: implications for the S-adenosylmethionine as a protective dietary activity supplement. J. Alzheimer Dis. 2008; 14: 323– 8.

Boldyrev AA. Molecular mechanisms of homocysteine toxicity. Biochem. (Moscow) 2009; 74: 589– 98.

Cararo JH, Streck EL, Schuck PF, Ferreira C. Carnosine and related peptides: potential in age-related disorders. Aging. Dis. 2015; 5: 369– 79.

Ko'rishlar soni: 50